Michael Reid is a seasoned Pharmacologist Consultant at Freeland PharmaConsulting Inc, where he plays a pivotal role in advancing pharmaceutical research and development. With over two decades of experience, Michael specializes in the intricate fields of immunology, inflammation, and ophthalmology, bringing a wealth of knowledge...
Michael Reid is a seasoned Pharmacologist Consultant at Freeland PharmaConsulting Inc, where he plays a pivotal role in advancing pharmaceutical research and development. With over two decades of experience, Michael specializes in the intricate fields of immunology, inflammation, and ophthalmology, bringing a wealth of knowledge and expertise to the table. His mission is clear: to contribute to the advancement of science and medicine through innovative and impactful research that addresses critical health challenges.
In his current role, Michael oversees pharmacokinetic (PK) bioanalytical processes and clinical pharmacodynamics (PD) biomarker analysis, focusing on optimizing drug dosing strategies for vulnerable patient populations, including geriatrics and pediatrics. His deep understanding of ADME (Absorption, Distribution, Metabolism, and Excretion) principles allows him to effectively guide dose adjustments, ensuring that therapeutic interventions are both safe and effective. Michael's proficiency in PK/PD modeling further enhances his ability to predict drug behavior in diverse populations, ultimately improving patient outcomes.
Michael's skill set is extensive, encompassing life sciences, biotechnology, and good laboratory practices (GLP). He is adept in the validation of analytical methods, particularly utilizing liquid chromatography-mass spectrometry (LC-MS) techniques, which are crucial for accurate bioanalytical assessments. His commitment to maintaining high standards through standard operating procedures (SOP) and his Six Sigma training underscore his dedication to quality and efficiency in clinical development. As a passionate R&D leader, Michael Reid continues to drive forward-thinking initiatives at Freeland PharmaConsulting Inc, embodying the spirit of innovation that is essential for the future of medicine.
